Bill Text: NY S08633 | 2023-2024 | General Assembly | Introduced

---

Bill Title: Requires notification by a prescriber or pharmacist of the substitution of one generic drug product for another generic drug product; requires both oral and written notification.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced) 2024-02-23 - REFERRED TO HIGHER EDUCATION [S08633 Detail]

Download: New_York-2023-S08633-Introduced.html

---

                STATE OF NEW YORK
        ________________________________________________________________________

                                          8633

                    IN SENATE

                                    February 23, 2024
                                       ___________

        Introduced  by  Sen.  CHU  --  read  twice and ordered printed, and when
          printed to be committed to the Committee on Higher Education

        AN ACT to amend the education law, in relation to  notification  of  the
          substitution of one generic drug product for another generic drug

          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Subdivision 6 of section  6810  of  the  education  law  is
     2  amended by adding a new paragraph (b-1) to read as follows:
     3    (b-1) The prescriber or pharmacist shall inform the patient whether he
     4  or  she  has  prescribed or substituted a different generic drug product
     5  from the generic drug  product  the  patient  has  previously  received.
     6  Notification  required pursuant to this paragraph shall be provided both
     7  written and orally.
     8    § 2. This act shall take effect on the ninetieth day  after  it  shall
     9  have become a law.







         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14465-01-4